Drug Description in Trials / DrugBank / KEGG DRUG
Search results
Showing 1 to 7 of 7 descriptions
| No. | 薬物名（臨床試験情報から抽出） | DrugBank | KEGG DRUG | KEGG GENES | KEGG PATHWAY | 指定難病告示番号 | ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | I.v. selexipag (Uptravi) | 1件: Selexipag Selexipag (UPTRAVI Titration Pack) | 1件: Selexipag
Selexipag
(Uptravi) 💬1. I.v. selexipag
| 1件: PTGIR PTGIR 💬1. I.v. selexipag
| 3件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬 3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction ... | 1件: 86 86 💬1. I.v. selexipag
| ||||||||||||||||
| 2 | Observational study with patients treated with Tracleer, Ventavis, Veletri, Opsumit and/or Uptravi | 4件: Epoprostenol Epoprostenol,Iloprost, Macitentan, Selexipag (UPTRAVI Titration Pack) | 4件: Epoprostenol
Epoprostenol
,Iloprost , Selexipag (Uptravi), Macitentan 💬 2. Observational study with patients treated with Tracleer, Ventavis, Veletri, Opsumit and/or Uptravi
| 3件: EDNRA EDNRA,EDNRB, PTGIR 💬 | 10件: Calcium signaling pathway Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Platelet activation, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 10件: Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in ... | 1件: 86 86 💬2. Observational study with patients treated with Tracleer, Ventavis, Veletri, Opsumit and/or Uptravi
| ||||||||||||||||
| 3 | Oral selexipag (Uptravi) | 1件: Selexipag Selexipag (UPTRAVI Titration Pack) | 1件: Selexipag
Selexipag
(Uptravi) 💬3. Oral selexipag (Uptravi)
| 1件: PTGIR PTGIR 💬3. Oral selexipag (Uptravi)
| 3件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬 3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction ... | 1件: 86 86 💬3. Oral selexipag (Uptravi)
| ||||||||||||||||
| 4 | SELEXIPAG (Uptravi) | 1件: Selexipag Selexipag (UPTRAVI Titration Pack) | 1件: Selexipag
Selexipag
(Uptravi) 💬4. SELEXIPAG
| 1件: PTGIR PTGIR 💬4. SELEXIPAG
| 3件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬 3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction ... | 5件: 51 51, 70, 84, 86, 88 💬
| ||||||||||||||||
| 5 | Selexipag (Uptravi) | 1件: Selexipag Selexipag (UPTRAVI Titration Pack) | 1件: Selexipag
Selexipag
(Uptravi) 💬5. Selexipag (Uptravi)
| 1件: PTGIR PTGIR 💬5. Selexipag (Uptravi)
| 3件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬 3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction ... | 1件: 86 86 💬5. Selexipag (Uptravi)
| ||||||||||||||||
| 6 | Selexipag, ACT-293987 (NS-304) (Uptravi) | 1件: Selexipag Selexipag (UPTRAVI Titration Pack) | 1件: Selexipag
Selexipag
(Uptravi) 💬6. Selexipag, ACT-293987 (NS-304)
| 1件: PTGIR PTGIR 💬6. Selexipag, ACT-293987 (NS-304)
| 3件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬 3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction ... | 1件: 86 86 💬6. Selexipag, ACT-293987 (NS-304)
| ||||||||||||||||
| 7 | Uptravi | 1件: Selexipag Selexipag (UPTRAVI Titration Pack) | 1件: Selexipag
Selexipag
(Uptravi) 💬7. Uptravi
| 1件: PTGIR PTGIR 💬7. Uptravi
| 3件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬 3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction ... | 3件: 84 84, 86, 88 💬
|